fda approves semaglutide 💉 The has approved (Ozempic) to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD) FDA approves Wegovy pill and

Retatrutide for Metabolic Diseases Retatrutide shows potential benefits for individuals with: Obesity and severe obesity Insulin resistance Prediabetes and metabolic syndrome Type 2 diabetes Fatty liver associated with metabolic dysfunction Its triple-agonist profile allows simultaneous intervention across the major biological drivers of metabolic disease

Apr 2010;10(4):315-331

Faculty are Board-Certified MDs with extensive clinical weight loss experience

A U.S.-licensed clinician independent of PlexusDx reviews your medical history and writes your prescription if you're eligible

Chemicals and drugs Dula was available as an injection-ready solution under the brand name TRULICITY from Lilly USA, LLC, US

A 2025 clinical trial found that Mounjaro provided similar cardiovascular protection to Trulicity (dulaglutide), and Eli Lilly submitted data to the FDA by the end of 2025 for approval of this indication